KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Novavax (NVAX) Long-Term Debt Issuances: 2012-2016

  • Novavax's Long-Term Debt Issuances was N/A to $325.0 million in Q1 2016 from the same period last year, while for Mar 2016 it was $327.0 million, marking a year-over-year change of. This contributed to the annual value of $175.2 million for FY2022, which is N/A change from last year.
  • Latest data reveals that Novavax reported Long-Term Debt Issuances of $325.0 million as of Q1 2016, which was up 50,602.03% from $641,000 recorded in Q2 2013.
  • In the past 5 years, Novavax's Long-Term Debt Issuances ranged from a high of $325.0 million in Q1 2016 and a low of $100,000 during Q1 2012.
  • In the last 1 years, Novavax's Long-Term Debt Issuances had a median value of $325.0 million in 2016 and averaged $325.0 million.
  • Data for Novavax's Long-Term Debt Issuances shows a peak YoY surged of 709.00% (in 2013) over the last 5 years.
  • Novavax's Long-Term Debt Issuances (Quarterly) stood at $550,000 in 2012, then soared by 709.00% to $641,000 in 2013, then reached $325.0 million in 2016.
  • Its last three reported values are $325.0 million in Q1 2016, $641,000 for Q2 2013, and $809,000 during Q1 2013.